Compound details
Pittosporanoside B1
| Compound ID | CDAMM01304 |
|---|---|
| Common name | Pittosporanoside B1 | IUPAC name | [3-acetyloxy-2-(3,7-dimethyl-10-propan-2-ylcyclodeca-2,6-dien-1-yl)oxy-5-hydroxy-6-methyloxan-4-yl] 2-methylbut-2-enoate |
| Molecular formula | C28H44O7 |
| Retention time | 0.42 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 493.319 | Theoretical mz | 493.316 |
| Error | 6.13 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.6803 |
| Inchi key | CCINNFNVGBXOKP-URJOXYHBNA-N |
|---|---|
| Smiles | O=C(OC1C(O)C(OC(OC2C=C(C)CCC=C(C)CCC2C(C)C)C1OC(=O)C)C)C(=CC)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P11229 | CHRM1 | Muscarinic acetylcholine receptor M1 | T28893 | SwissTargetPrediction |
| P20309 | CHRM3 | Muscarinic acetylcholine receptor M3 | T67684 | SwissTargetPrediction |
| P36544 | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | T34429 | SwissTargetPrediction |
| P29475 | NOS1 | Nitric-oxide synthase, brain | T16117 | SwissTargetPrediction |
| P00797 | REN | Renin | T61622 | SwissTargetPrediction |
| P54289 | CACNA2D1 | Voltage-gated calcium channel alpha2/delta subunit 1 (by homology) | T84316 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P11712 | CYP2C9 | Cytochrome P450 2C9 | T19244 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P31645 | SLC6A4 | Serotonin transporter (by homology) | T27812 | SwissTargetPrediction |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SwissTargetPrediction |
| P34969 | HTR7 | Serotonin 7 (5-HT7) receptor | T79062 | SwissTargetPrediction |
| P24864 | CCNE1 | Cyclin-dependent kinase 2/cyclin E1 | T10052 | SwissTargetPrediction |
| P56524 | HDAC4 | Histone deacetylase 4 | T63816 | SwissTargetPrediction |
| Q9UBN7 | HDAC6 | Histone deacetylase 6 | T22274 | SwissTargetPrediction |
| P15538 | CYP11B1 | Cytochrome P450 11B1 | T84621 | SwissTargetPrediction |
| P19099 | CYP11B2 | Cytochrome P450 11B2 | T59056 | SwissTargetPrediction |
| P07384 | CAPN1 | Calpain 1 | T92517 | SwissTargetPrediction |
| P07339 | CTSD | Cathepsin D | T67102 | SwissTargetPrediction |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| Q13547 | HDAC1 | Histone deacetylase 1 | T68547 | SwissTargetPrediction |
| P08069 | IGF1R | Insulin-like growth factor I receptor | T48069 | SwissTargetPrediction |
| P04626 | ERBB2 | Receptor protein-tyrosine kinase erbB-2 | T14597 | SwissTargetPrediction |
| P00519 | ABL1 | Tyrosine-protein kinase ABL | T63505 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| P06213 | INSR | Insulin receptor | T85435 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | T85799 | SwissTargetPrediction |
| P78536 | ADAM17 | ADAM17 | T82393 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P08172 | CHRM2 | Muscarinic acetylcholine receptor M2 | T46185 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| P37288 | AVPR1A | Vasopressin V1a receptor (by homology) | T79232 | SwissTargetPrediction |
| O43603 | GALR2 | Galanin receptor 2 (by homology) | T13453 | SwissTargetPrediction |
| P47211 | GALR1 | Galanin receptor 1 (by homology) | T78581 | SwissTargetPrediction |
| P51449 | RORC | Nuclear receptor ROR-gamma | T25307 | SwissTargetPrediction |
| Q08499 | PDE4D | Phosphodiesterase 4D | T02001 | SwissTargetPrediction |
| P24723 | PRKCH | Protein kinase C eta | T40149 | SwissTargetPrediction |
| Q15722 | LTB4R | Leukotriene B4 receptor 1 | T59626 | SwissTargetPrediction |
| P11137 | MAP2 | Microtubule-associated protein 2 | T23276 | SwissTargetPrediction |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P32246 | CCR1 | C-C chemokine receptor type 1 | T16016 | SwissTargetPrediction |
| P05771 | PRKCB | Protein kinase C beta | T40276 | SwissTargetPrediction |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| P29466 | CASP1 | Caspase-1 | T98269 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P24385 | CCND1 | Cyclin-dependent kinase 4/cyclin D1 | T12355 | SwissTargetPrediction |
| P40763 | STAT3 | Signal transducer and activator of transcription 3 | T29130 | SwissTargetPrediction |
| Q12884 | FAP | Fibroblast activation protein alpha (by homology) | T53764 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| Q05655 | PRKCD | Protein kinase C delta | T44861 | SwissTargetPrediction |
| P04062 | GBA | Beta-glucocerebrosidase | T84173 | SwissTargetPrediction |
| P28482 | MAPK1 | MAP kinase ERK2 | T58970 | SwissTargetPrediction |
| P34995 | PTGER1 | Prostanoid EP1 receptor | T15497 | SwissTargetPrediction |
| P05023 | ATP1A1 | Sodium/potassium-transporting ATPase alpha-1 chain | T40800 | SwissTargetPrediction |
| P23415 | GLRA1 | Glycine receptor subunit alpha-1 | T50269 | SwissTargetPrediction |
| P48167 | GLRB | Glycine receptor | T55285 | SwissTargetPrediction |
| P04629 | NTRK1 | Nerve growth factor receptor Trk-A | T07173 | SwissTargetPrediction |
| P50613 | CDK7 | Cyclin-dependent kinase 7 | T58449 | SwissTargetPrediction |
| P50750 | CDK9 | Cyclin-dependent kinase 9 | T44458 | SwissTargetPrediction |
| Q00535 | CDK5 | Cyclin-dependent kinase 5/CDK5 activator 1 | T20973 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| P25025 | CXCR2 | Interleukin-8 receptor B | T56923 | SwissTargetPrediction |
| Q15172 | PPP2R5A | Serine/threonine protein phosphatase 2A, 56 kDa regulatory subunit, alpha isoform | T57291 | SwissTargetPrediction |
| P67775 | PPP2CA | Serine/threonine protein phosphatase 2A, catalytic subunit, alpha isoform | T40491 | SwissTargetPrediction |
| Q9Y5Z0 | BACE2 | Beta secretase 2 | T01280 | SwissTargetPrediction |
| P32239 | CCKBR | Cholecystokinin B receptor (by homology) | T05849 | SwissTargetPrediction |
| Q9UQ81 | MCH5 | Caspase-8 | T15700 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| P56373 | P2RX3 | P2X purinoceptor 3 | T17140 | SwissTargetPrediction |
| P28074 | PSMB5 | Proteasome Macropain subunit MB1 | T49031 | SwissTargetPrediction |
| O43614 | HCRTR2 | Orexin receptor 2 | T69485 | SwissTargetPrediction |
| O43613 | HCRTR1 | Orexin receptor 1 | T73482 | SwissTargetPrediction |
| P23109 | AMPD1 | AMP deaminase 1 | T84553 | SwissTargetPrediction |
| Q9GZN0 | GPR88 | Probable G-protein coupled receptor 88 | T37505 | SwissTargetPrediction |
| P55201 | BRPF1 | Peregrin | T41145 | SwissTargetPrediction |
| O60706 | ABCC9 | Sulfonylurea receptor 2 | T02777 | SwissTargetPrediction |
| P00746 | CFD | Complement factor D | T66383 | SwissTargetPrediction |
| Q9Y5X9 | LIPG | Endothelial lipase | T19368 | SwissTargetPrediction |
| P10415 | BCL2 | Apoptosis regulator Bcl-2 | T31309 | SwissTargetPrediction |
| P49238 | CX3CR1 | C-X3-C chemokine receptor 1 | T15033 | SwissTargetPrediction |
| P28065 | PSMB9 | Proteasome subunit beta type-9 | T06792 | SwissTargetPrediction |
| O96013 | PAK4 | Serine/threonine-protein kinase PAK 4 | T98293 | SwissTargetPrediction |
| P47901 | AVPR1B | Vasopressin V1b receptor | T59881 | SwissTargetPrediction |
| Q9NY47 | CACNA2D2 | Voltage-gated calcium channel alpha2/delta subunit 2 | T28132 | SwissTargetPrediction |
| Q99814 | EPAS1 | Endothelial PAS domain-containing protein 1 | T21123 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T28893 | DI0001 | Abdominal pelvic pain | [ICD-11: MD81] | P11229 | CHRM1 |
| T28893 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P11229 | CHRM1 |
| T28893 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P11229 | CHRM1 |
| T28893 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | P11229 | CHRM1 |
| T28893 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P11229 | CHRM1 |
| T28893 | DI0157 | Gastric ulcer | [ICD-11: DA60] | P11229 | CHRM1 |
| T28893 | DI0166 | Glaucoma | [ICD-11: 9C61] | P11229 | CHRM1 |
| T28893 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P11229 | CHRM1 |
| T28893 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P11229 | CHRM1 |
| T28893 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P11229 | CHRM1 |
| T28893 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P11229 | CHRM1 |
| T28893 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P11229 | CHRM1 |
| T67684 | DI0037 | Asthma | [ICD-11: CA23] | P20309 | CHRM3 |
| T67684 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P20309 | CHRM3 |
| T67684 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P20309 | CHRM3 |
| T67684 | DI0166 | Glaucoma | [ICD-11: 9C61] | P20309 | CHRM3 |
| T67684 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P20309 | CHRM3 |
| T67684 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P20309 | CHRM3 |
| T67684 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P20309 | CHRM3 |
| T67684 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P20309 | CHRM3 |
| T67684 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P20309 | CHRM3 |
| T67684 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P20309 | CHRM3 |
| T34429 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P36544 | CHRNA7 |
| T34429 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P36544 | CHRNA7 |
| T16117 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P29475 | NOS1 |
| T16117 | DI0264 | Migraine | [ICD-11: 8A80] | P29475 | NOS1 |
| T61622 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P00797 | REN |
| T84316 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P54289 | CACNA2D1 |
| T84316 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P54289 | CACNA2D1 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T19244 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P11712 | CYP2C9 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T27812 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P31645 | SLC6A4 |
| T27812 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P31645 | SLC6A4 |
| T27812 | DI0087 | Chronic pain | [ICD-11: MG30] | P31645 | SLC6A4 |
| T27812 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P31645 | SLC6A4 |
| T27812 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P31645 | SLC6A4 |
| T27812 | DI0105 | Cough | [ICD-11: MD12] | P31645 | SLC6A4 |
| T27812 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P31645 | SLC6A4 |
| T27812 | DI0264 | Migraine | [ICD-11: 8A80] | P31645 | SLC6A4 |
| T27812 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P31645 | SLC6A4 |
| T27812 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P31645 | SLC6A4 |
| T27812 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P31645 | SLC6A4 |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T79062 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P34969 | HTR7 |
| T79062 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34969 | HTR7 |
| T79062 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P34969 | HTR7 |
| T79062 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P34969 | HTR7 |
| T79062 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P34969 | HTR7 |
| T79062 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P34969 | HTR7 |
| T79062 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P34969 | HTR7 |
| T63816 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P56524 | HDAC4 |
| T22274 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9UBN7 | HDAC6 |
| T22274 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UBN7 | HDAC6 |
| T84621 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P15538 | CYP11B1 |
| T84621 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P15538 | CYP11B1 |
| T59056 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P19099 | CYP11B2 |
| T67102 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07339 | CTSD |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T68547 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q13547 | HDAC1 |
| T68547 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | Q13547 | HDAC1 |
| T48069 | DI0276 | Multiple structural anomalies syndrome | [ICD-11: LD2F] | P08069 | IGF1R |
| T48069 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P08069 | IGF1R |
| T48069 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P08069 | IGF1R |
| T14597 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P04626 | ERBB2 |
| T14597 | DI0238 | Lung cancer | [ICD-11: 2C25] | P04626 | ERBB2 |
| T14597 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P04626 | ERBB2 |
| T63505 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00519 | ABL1 |
| T63505 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00519 | ABL1 |
| T63505 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P00519 | ABL1 |
| T63505 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00519 | ABL1 |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T85435 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P06213 | INSR |
| T85435 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P06213 | INSR |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T85799 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11802 | CDK4 |
| T85799 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11802 | CDK4 |
| T85799 | DI0351 | Psoriasis | [ICD-11: EA90] | P11802 | CDK4 |
| T82393 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P78536 | ADAM17 |
| T82393 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P78536 | ADAM17 |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T46185 | DI0037 | Asthma | [ICD-11: CA23] | P08172 | CHRM2 |
| T46185 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08172 | CHRM2 |
| T46185 | DI0278 | Muscle disorder | [ICD-11: FB32-FB3Z] | P08172 | CHRM2 |
| T46185 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08172 | CHRM2 |
| T46185 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08172 | CHRM2 |
| T46185 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P08172 | CHRM2 |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T79232 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P37288 | AVPR1A |
| T79232 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P37288 | AVPR1A |
| T79232 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P37288 | AVPR1A |
| T79232 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P37288 | AVPR1A |
| T79232 | DI0236 | Localisation | [ICD-11: N.A.] | P37288 | AVPR1A |
| T78581 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P47211 | GALR1 |
| T25307 | DI0042 | Autoimmune disease | [ICD-11: 4A40-4A45] | P51449 | RORC |
| T25307 | DI0107 | Crohn disease | [ICD-11: DD70] | P51449 | RORC |
| T25307 | DI0238 | Lung cancer | [ICD-11: 2C25] | P51449 | RORC |
| T25307 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P51449 | RORC |
| T25307 | DI0351 | Psoriasis | [ICD-11: EA90] | P51449 | RORC |
| T25307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P51449 | RORC |
| T02001 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q08499 | PDE4D |
| T40149 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P24723 | PRKCH |
| T59626 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | Q15722 | LTB4R |
| T59626 | DI0355 | Pulmonary disease | [ICD-11: 1B10-1F85] | Q15722 | LTB4R |
| T59626 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | Q15722 | LTB4R |
| T23276 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P11137 | MAP2 |
| T23276 | DI0252 | Melanoma | [ICD-11: 2C30] | P11137 | MAP2 |
| T23276 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P11137 | MAP2 |
| T23276 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11137 | MAP2 |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T16016 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P32246 | CCR1 |
| T16016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P32246 | CCR1 |
| T40276 | DI0123 | Diffuse large B-cell lymphoma | [ICD-11: 2A81] | P05771 | PRKCB |
| T40276 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P05771 | PRKCB |
| T40276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P05771 | PRKCB |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T98269 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P29466 | CASP1 |
| T98269 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P29466 | CASP1 |
| T98269 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P29466 | CASP1 |
| T98269 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P29466 | CASP1 |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T12355 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P24385 | CCND1 |
| T29130 | DI0351 | Psoriasis | [ICD-11: EA90] | P40763 | STAT3 |
| T53764 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q12884 | FAP |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T44861 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q05655 | PRKCD |
| T84173 | DI0257 | Metabolic disorder | [ICD-11: 5C50-5D2Z] | P04062 | GBA |
| T58970 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P28482 | MAPK1 |
| T58970 | DI0252 | Melanoma | [ICD-11: 2C30] | P28482 | MAPK1 |
| T58970 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P28482 | MAPK1 |
| T58970 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28482 | MAPK1 |
| T15497 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P34995 | PTGER1 |
| T40800 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | P05023 | ATP1A1 |
| T40800 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P05023 | ATP1A1 |
| T40800 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P05023 | ATP1A1 |
| T40800 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P05023 | ATP1A1 |
| T40800 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P05023 | ATP1A1 |
| T40800 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P05023 | ATP1A1 |
| T40800 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P05023 | ATP1A1 |
| T50269 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P23415 | GLRA1 |
| T55285 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P48167 | GLRB |
| T07173 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04629 | NTRK1 |
| T07173 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04629 | NTRK1 |
| T58449 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P50613 | CDK7 |
| T58449 | DI0238 | Lung cancer | [ICD-11: 2C25] | P50613 | CDK7 |
| T58449 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P50613 | CDK7 |
| T58449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50613 | CDK7 |
| T44458 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P50750 | CDK9 |
| T44458 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P50750 | CDK9 |
| T44458 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P50750 | CDK9 |
| T44458 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P50750 | CDK9 |
| T44458 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P50750 | CDK9 |
| T44458 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P50750 | CDK9 |
| T44458 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50750 | CDK9 |
| T20973 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q00535 | CDK5 |
| T56923 | DI0155 | Fungal infection | [ICD-11: 1F29-1F2F] | P25025 | CXCR2 |
| T56923 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25025 | CXCR2 |
| T40491 | DI0268 | Molluscum contagiosum | [ICD-11: 1E76] | P67775 | PPP2CA |
| T01280 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | Q9Y5Z0 | BACE2 |
| T05849 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P32239 | CCKBR |
| T05849 | DI0327 | Pancreatic internal secretion disorder | [ICD-11: 5A4Y] | P32239 | CCKBR |
| T15700 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | Q9UQ81 | MCH5 |
| T15700 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UQ81 | MCH5 |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T17140 | DI0105 | Cough | [ICD-11: MD12] | P56373 | P2RX3 |
| T69485 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43614 | HCRTR2 |
| T73482 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O43613 | HCRTR1 |
| T73482 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43613 | HCRTR1 |
| T73482 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | O43613 | HCRTR1 |
| T02777 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O60706 | ABCC9 |
| T02777 | DI0030 | Angina pectoris | [ICD-11: BA40] | O60706 | ABCC9 |
| T02777 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | O60706 | ABCC9 |
| T66383 | DI0170 | Haemolytic anemia | [ICD-11: 3A20-3A2Z] | P00746 | CFD |
| T66383 | DI0365 | Retinopathy | [ICD-11: 9B71] | P00746 | CFD |
| T19368 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | Q9Y5X9 | LIPG |
| T19368 | DI0091 | Coagulation defect | [ICD-11: 3B10] | Q9Y5X9 | LIPG |
| T19368 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q9Y5X9 | LIPG |
| T31309 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10415 | BCL2 |
| T31309 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P10415 | BCL2 |
| T31309 | DI0273 | Motor neuron disease | [ICD-11: 8B60] | P10415 | BCL2 |
| T31309 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P10415 | BCL2 |
| T98293 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O96013 | PAK4 |
| T98293 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O96013 | PAK4 |
| T59881 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P47901 | AVPR1B |
| T59881 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P47901 | AVPR1B |
| T59881 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P47901 | AVPR1B |
| T21123 | DI0019 | Adrenomedullary hyperfunction | [ICD-11: 5A75] | Q99814 | EPAS1 |